Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Stribild Superior to Boosted Atazanavir in Treatment-Naive Women

Stribild proved virologically superior to atazanavir/ritonavir plus tenofovir/emtricitabine (TDF/FTC) at 48 weeks in WAVES, an international trial in 575 antiretroviral-naive women. No one in the Stribild arm had emergent resistance upon virologic failure, compared with 3 women in the atazanavir arm.

Published
27 July 2015
From
NATAP
The Day the HIV Treatment Pendulum Stopped Swinging

Normally at scientific conferences, even when study findings are considered to be major, a single researcher stands at a podium for 10 or 15 minutes, takes the audience on a guided PowerPoint tour of charts and graphs, receives a round of applause, and fields a few questions. Then the session moves on to its next topic. The presentation of the START findings was different.

Published
23 July 2015
From
The Body Pro
Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco

A programme at San Francisco General Hospital that offers antiretroviral therapy (ART) on the same day as HIV diagnosis led to a high rate of treatment uptake

Published
23 July 2015
By
Liz Highleyman
IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Study also showed that most commonly used measure — CD4 count does not give accurate projection of illness risk.

Published
21 July 2015
From
Science Speaks
START trial provides definitive evidence of the benefits of early HIV treatment

People who start antiretroviral therapy (ART) immediately after HIV diagnosis, while their CD4 cell count is still high, rather than waiting until it falls below 350 cells/mm3

Published
21 July 2015
By
Liz Highleyman
Young woman stays undetectable for twelve years off treatment after early HIV therapy

The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) heard today of a case where a young woman, who was infected with

Published
21 July 2015
By
Gus Cairns
Prompt ART especially important for people with HIV aged 45 and over

Delaying antiretroviral therapy (ART) may have especially serious consequences for middle-aged and elderly HIV-positive people, according to research published in Clinical Infectious Diseases. US investigators found that patients aged

Published
08 July 2015
By
Michael Carter
NHS England announces annual investment decisions for certain specialised services [including HIV treatment as prevention]

NHS England has today (2 July) set out its planned investment decisions for certain specialised services as part of its annual commissioning round.

Published
03 July 2015
From
NHS England press release
New British guidelines recommend treatment for everyone with HIV

Everyone with HIV who is prepared to take antiretroviral treatment should receive it, regardless of CD4 cell count, new draft British HIV Association (BHIVA) treatment guidelines

Published
24 June 2015
By
Keith Alcorn
START Making Sense

The story of the START trial will continue to be told for a long time to come. For some it will be a tale of rigorous perseverance in the face of strong counter-prevailing headwinds and ultimate arrival at a result that is solid and conclusive. Others will see a single-minded and aggressive defense of a trial by investigators who refused to accept not only the obvious but also the evidence that rendered their design obsolete and even unethical.

Published
19 June 2015
From
North Carolina AIDS Training and Education Center
← First12345...68Next →

Filter by country